Literature DB >> 18756507

Distinctions between fetal and adult human platelet-derived growth factor-responsive neural precursors.

Andrew Chojnacki1, John J P Kelly, Walter Hader, Samuel Weiss.   

Abstract

OBJECTIVE: Platelet-derived growth factor (PDGF)-responsive neural precursors (PRPs; also known as oligodendrocyte progenitor cells) are one of the best characterized precursor cell populations of the rodent central nervous system. Yet little is known about the biology of human PRPs because of an apparent inability to culture and expand them in large numbers. This study was designed to establish an approach that allows direct comparisons between the biology of fetal and adult human PRPs, as a means to address potential differences in intrinsic myelin-production capabilities.
METHODS: We used the neurosphere culture system, under low plating density, to isolate, culture, and compare the properties of fetal and adult human PRPs.
RESULTS: PDGF stimulated fetal human PRPs to generate neurospheres that differentiated primarily into oligodendrocytes, which acquired myelin basic protein expression, as well as neurons and a small number of astrocytes. Together with PDGF, fibroblast growth factor 2 promoted fetal human PRP expansion. In contrast, adult human PRPs isolated from the corpus callosum required twice the culture period to generate neurospheres, which contained oligodendrocytes, as well as astrocytes, but not neurons. Strikingly, fibroblast growth factor 2 did not promote adult human PRP self-renewal.
INTERPRETATION: Differences in the intrinsic proliferation, phenotype, and self-renewal properties of fetal and adult human PRPs suggest they are distinct populations, which may result in distinct myelin-production capabilities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18756507     DOI: 10.1002/ana.21421

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  9 in total

1.  NG2 cells in white matter but not gray matter proliferate in response to PDGF.

Authors:  Robert A Hill; Kiran D Patel; Jelena Medved; Alex M Reiss; Akiko Nishiyama
Journal:  J Neurosci       Date:  2013-09-04       Impact factor: 6.167

Review 2.  Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

Review 3.  PDGF/PDGFR axis in the neural systems.

Authors:  Susmita Sil; Palsamy Periyasamy; Annadurai Thangaraj; Ernest T Chivero; Shilpa Buch
Journal:  Mol Aspects Med       Date:  2018-02-06

4.  On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.

Authors:  Owen D Stechishin; H Artee Luchman; Yibing Ruan; Michael D Blough; Stephanie A Nguyen; John J Kelly; J Gregory Cairncross; Samuel Weiss
Journal:  Neuro Oncol       Date:  2012-12-21       Impact factor: 12.300

Review 5.  Neural stem cell niches in health and diseases.

Authors:  Ilaria Decimo; Francesco Bifari; Mauro Krampera; Guido Fumagalli
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

6.  PD-1 independent of PD-L1 ligation promotes glioblastoma growth through the NFκB pathway.

Authors:  Reza Mirzaei; Ashley Gordon; Franz J Zemp; Mehul Kumar; Susobhan Sarkar; H Artee Luchman; Anita C Bellail; Chunhai Hao; Douglas J Mahoney; Jeff F Dunn; Pinaki Bose; V Wee Yong
Journal:  Sci Adv       Date:  2021-11-05       Impact factor: 14.136

7.  PDGF-responsive progenitors persist in the subventricular zone across the lifespan.

Authors:  Lisamarie Moore; Jennifer M Bain; Ji Meng Loh; Steven W Levison
Journal:  ASN Neuro       Date:  2014-02-07       Impact factor: 4.146

Review 8.  The roles of PDGF in development and during neurogenesis in the normal and diseased nervous system.

Authors:  Keiko Funa; Masakiyo Sasahara
Journal:  J Neuroimmune Pharmacol       Date:  2013-06-15       Impact factor: 4.147

9.  Fibrinogen in the glioblastoma microenvironment contributes to the invasiveness of brain tumor-initiating cells.

Authors:  Lauren Dzikowski; Reza Mirzaei; Susobhan Sarkar; Mehul Kumar; Pinaki Bose; Anita Bellail; Chunhai Hao; V Wee Yong
Journal:  Brain Pathol       Date:  2021-03-10       Impact factor: 6.508

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.